New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2014
08:53 EDTCICigna management to meet with Deutsche Bank
Meeting to be held in New York on February 11 hosted by Deutsche Bank.
News For CI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
06:16 EDTCICigna reports Q4-end Commercial customers 14.43M, Government customers 567K
Reports Q4 Total Commercial medical care ratio of 80.4%, Total Government medical care ratio of 83.1%. Full year medical cost trend for our total U.S. Commercial book of business was approximately 5% and reflects continued favorable medical costs, physician engagement and low utilization trend.
06:15 EDTCICigna unlikely to make further share repurchases in 2016
Cites the pending combination with Anthem.
06:03 EDTCICigna sees FY16 adjusted EPS $8.85-$9.25, consensus $9.30
Subscribe for More Information
06:02 EDTCICigna reports Q4-end global medical customers 14.99M
Subscribe for More Information
06:01 EDTCICigna reports Q4 adjusted EPS $1.87, consensus $1.80
Reports Q4 revenue $9.53B, consensus $9.52B.
February 3, 2016
14:48 EDTCINotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Philip Morris (PM), consensus 81c... AstraZeneca (AZN), consensus 88c... Occidental Petroleum (OXY), consensus (12c)... ConocoPhillips (COP), consensus (65c)... Cigna (CI), consensus $1.80... Intercontinental Exchange (ICE), consensus $3.01... Boston Scientific (BSX), consensus 25c... Charter Communications (CHTR), consensus (12c)... Ralph Lauren (RL), consensus $2.13... Dunkin' Brands (DNKN), consensus 50c... GrubHub (GRUB), consensus 14c... Level 3 (LVLT), consensus 53c... AmerisourceBergen (ABC), consensus $1.25... Cummins (CMI), consensus $2.11.
06:55 EDTCICigna volatility elevated into Q4 and outlook
Cigna February call option implied volatility is at 28, March is at 29 ; compared to its 52-week range of 18 to 39, suggesting large near term price movement into the expected release of Q4 results on February 4.
January 29, 2016
14:24 EDTCIEarnings Watch: Aetna down 9% since last report
Aetna (AET) is scheduled to report fourth quarter earnings before the market open on Monday, February 1, with a conference call scheduled for 8:30 am ET. Aetna, a diversified health care benefits company in the United States, operates in three segments: Health Care, Group Insurance, and Large Case Pensions. EXPECTATIONS: Analysts are looking for earnings per share of $1.21 on revenue of $14.93B, according to First Call. The consensus range for EPS is $1.16-$1.32 on revenue of $14.44B-$15.36B. LAST QUARTER: Aetna reported third quarter EPS of $1.90 on revenue of $14.97B against analyst estimates of $1.77 and $14.95B, respectively. The company raised its fiscal 2015 EPS view to $7.45-$7.55 from "at least $7.40." Operating earnings were $668.6M for Q315 compared with $638.6M for Q314. The increase in operating earnings was primarily due to higher underwriting margins in Aetna's Health Care segment, partially offset by an increase in general and administrative expenses and lower underwriting margins in Aetna's Group Insurance segment. On January 11, Aetna said it see FY15 EPS at the high end of the $7.45-$7.55 range. Consensus for FY15 EPS is $7.54. STREET RESEARCH: On January 15, Wells Fargo said it expects health insurers' stock to do well this year, as the firm expects M&A deals made the last years to increase profits this year, and it thinks investors should be attracted to what it sees as the defensive names in the sector. Wells does not believe that any changes to or replacements of the ACA will be worse for the sector than the status quo. It identified Aetna and HCA Holdings (HCA) as its favorite names in the sector. On January 25, Leerink analyst Ana Gupte said she believed the recent selloff has provided a "strong" buying opportunity in the Managed Care space. Valuations are attractive on multiple metrics, Gupte told investors in a research note. Her top picks are UnitedHealth (UNH), Aetna, Humana (HUM) and Molina Healthcare (MOH). The analyst also favors Anthem (ANTM) and Cigna (CI). PRICE ACTION: Shares of Aetna are down approximately 9% since its last earnings report. The stock is up 2.6% to $101.42 in Friday afternoon trading ahead of Monday morning's report.
January 25, 2016
09:08 EDTCICalifornia seen asking for few remedies in health insurance mergers, CTFN says
Subscribe for More Information
08:23 EDTCILeerink sees 'strong' buying opportunity in Managed Care space
Subscribe for More Information
January 22, 2016
11:07 EDTCICigna pullback on sanctions presents buying opportunity, says Citi
Citi analyst Ralph Giacobbe noted that the CMS sanctions and enrollment suspension imposed on Cigna's (CI) Medicare Advantage and PDP plans don't impact current members and are a tool used by CMS to force Cigna to tighten up perceived deficiencies with its operations. Giacobbe expects management to remediate these issues as soon as possible and recommends using any pullback in Cigna as a buying opportunity, as he continues to view its Anthem (ANTM) deal as a positive catalyst.
10:16 EDTCICigna sanctions unlikely to impact Anthem deal closing, says Sterne Agee CRT
Subscribe for More Information
08:07 EDTCICigna down 3% after reporting CMS sanctions on Medicare Advantage contracts
08:05 EDTCICigna says CMS to impose sanctions on Medicare Advantage contracts
In a regulatory filing, Cigna announced it was notified by the Centers for Medicare & Medicaid Services, or CMS, of its intent to impose intermediate sanctions suspending the enrollment of and marketing to new customers of all Cigna Medicare Advantage and Standalone Prescription Drug Plan Contracts, effective at 11:59 p.m. on January 21. The suspension does not impact current Cigna Medicare Advantage and Medicare Part D enrollees' benefits or plans, Cigna noted. The company said: "CMS imposed sanctions due to deficiencies discovered with Cigna's operations of its Parts C and D appeals and grievances, Part D formulary and benefit administration, and compliance program. Cigna is working to resolve these matters as quickly as possible and is cooperating fully with CMS on its review. Cigna is committed to its customers and ensuring that its customers have access to the quality healthcare, customer service and prescription drugs that they need."

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use